Printer Friendly

Emergency Filtration Products Starts Shipping Child NanoMask; Company Names Global Protection as New Distributor.

HENDERSON, Nev. -- Emergency Filtration Products, Inc. (EFP) (OTCBB: EMFP) today announced that it has begun shipping a smaller version of the NanoMask. This facemask is identical in its performance characteristics to the adult version, but is smaller in order to better fit children and individuals for whom the adult NanoMask is too large. The suggested retail selling price for one NanoMask and two NanoMask filters is $14.95. Initial orders received for the child NanoMask and child NanoMask filters alone exceed $300,000.

Separately, the company also announced that it had entered into a distribution agreement with Global Protection Acquisition Inc. a, West Berlin, New Jersey based company that specializes in Homeland Security products.

"Global Protection is one of our leading U.S. distributors, has a strong presence throughout the United States and also distributes in Asia and Europe," said Douglas K. Beplate, President & CEO, EFP. "We are delighted to have them on board and look forward to helping them meet their NanoMask sales objectives."

"With the threat of the impending bird flu pandemic, government agencies on all levels are preparing to stockpile hundreds of millions of respirators," said Steven Guarino, President, Global Protection. "Every major corporation is looking to protect their employees. We are currently in discussions with a number of large corporations and government agencies that are planning multi-million dollar budgets for respirator purchases and other bird flu preparedness measures. Global Protection is at the forefront of supplying these corporations and government agencies." Mr. Guarino added, "We are strong believers in the NanoMask and are confident that we will be able to sell a large number of NanoMasks and NanoMask filters over the coming year."

About Global Protection (

Global Protection offers First Responder protective gear which includes: protective suits, gas masks, and a variety of equipment used for protection against chemical, biological, and nuclear threats. US government agencies, police and fire first responders, companies and individuals rely on Global Protection to provide the leading products to protect against potential chemical warfare agents, biological warfare, and terrorist threats such as anthrax, smallpox, and nerve gas.

For further information contact: Lou Schiliro, Director of Operations 1-800-957-8955

About Emergency Filtration Products (

EFP is an air filtration products manufacturer whose patented 2H Technology(TM) filter system has produced filtration efficiencies of "greater than 99.99%" at a particulate size of 0.027 microns. Its initial products were developed for the medical market: the Vapor Isolation Valve(TM) and RespAide(R) CPR Isolation Mask used for resuscitation of respiratory/cardiac arrest cases; and the 2H Breathing Circuit Filter for ventilators, respirators and anesthesia circuitry. Each has received FDA approval. The company also markets an Automated External Defibrillator Prep Kit featuring RespAide; and the NanoMask(R), a nanotechnology enhanced environmental mask. In addition to filtration products, the company supplies Superstat(R), a modified hemostatic collagen, to the U.S. military for surgery and extreme wound care.

Safe Harbor Statement

This release may contain statements that are forward looking. Such statements are made based upon current expectations that are subject to risk and uncertainty. EFP does not undertake to update forward-looking statements in this news release to reflect actual results of and changes in assumptions or changes in other factors affecting such forward-looking information. The actual future results of the company could differ significantly from such forward-looking statements. Sales may be dependent on the success of future marketing campaigns, the signing of definitive agreements with additional distributors, and both the perceived need for EFP's products and the competitive performance of such products in the marketplace.
COPYRIGHT 2006 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:Jun 9, 2006
Previous Article:Hana Biosciences Receives Orphan Drug Designation for Ropidoxuridine (IPdR), for the Treatment of Malignant Glioma.
Next Article:Latin American and Caribbean Economic Expansion Expected to Continue Unabated in 2006.

Related Articles
Bioterrorism threat breeds ideas.
$660M Bronx golf course gets green light from court.
Nonelectric suction system.
Emergency Filtration Products In Production.
Emergency Filtration Products 2005 Year-End Progress Report.

Terms of use | Copyright © 2018 Farlex, Inc. | Feedback | For webmasters